Cargando…
Immune response to SARS-CoV-2 in severe disease and long COVID-19
COVID-19 is mild to moderate in otherwise healthy individuals but may nonetheless cause life-threatening disease and/or a wide range of persistent symptoms. The general determinant of disease severity is age mainly because the immune response declines in aging patients. Here, we developed a mathemat...
Autores principales: | Sumi, Tomonari, Harada, Kouji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251893/ https://www.ncbi.nlm.nih.gov/pubmed/35813874 http://dx.doi.org/10.1016/j.isci.2022.104723 |
Ejemplares similares
-
Mechanism underlying hippocampal long-term potentiation and depression based on competition between endocytosis and exocytosis of AMPA receptors
por: Sumi, Tomonari, et al.
Publicado: (2020) -
Kinetics of the ancestral carbon metabolism pathways in deep-branching bacteria and archaea
por: Sumi, Tomonari, et al.
Publicado: (2021) -
Muscarinic acetylcholine receptor-dependent and NMDA receptor-dependent LTP and LTD share the common AMPAR trafficking pathway
por: Sumi, Tomonari, et al.
Publicado: (2023) -
Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients
por: Olea, Beatriz, et al.
Publicado: (2021) -
Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan
por: Lyu, Zhaoqing, et al.
Publicado: (2020)